Study Identifies a Potential New Target for Treatment of Gout

 Published in the journal Cellular and Molecular Immunology , their study suggests that blocking a signaling molecule known as TAK1 can suppress inflammation caused by gout. Full story.  

TRPV1 promotes opioid analgesia during inflammation

 Abstract: Pain and inflammation are inherently linked responses to injury, infection, or chronic diseases. Given that acute inflammation in humans or mice enhances the analgesic properties of opioids, there is much interest in determining the inflammatory transducers that prime opioid receptor signaling in primary afferent nociceptors.

Continue reading

Pairing Music with Medication Offers Potential Therapeutic Strategy to Manage Pain

Pairing music with ibuprofen improved analgesic outcomes in an inflammation pain mouse model by more than 90 percent, while the cannabidiol-music and galanin analog NAX 5055-music pairings significantly reduced inflammation by 70 percent. 

Continue reading

The AAPM Annual Meeting offers education and networking opportunities for all members of the pain care team.

Learn More